Gynecology
Expert Commentary
Do women treated with ceftriaxone and doxycycline for PID benefit from added metronidazole to broaden anaerobic coverage?
Yes, results from a randomized trial noted a therapeutic benefit in women with pelvic inflammatory disease (PID) who were...
Clinical Review
Telemedicine: A primer for today’s ObGyn
Ready or not, you should be embracing the technology. Here’s how to get started.
If telemedicine had not yet begun to play...
App Review
COVID-19 apps for the ObGyn health care provider
Three apps to help clinicians keep up with COVID-19 information and treatment guidance
Expert Commentary
COVID-19 and pregnancy: Is miscarriage a risk?
Latest News
Ob.gyns., peds, other PCPs seeking COVID-19 financial relief from feds
A handful of specialties are calling for targeted relief payments from the federal government, saying that they have been left out of...
Conference Coverage
Menstrual cup use with copper IUDs linked to higher expulsion rates
“The study is innovative and important in being the first prospective study to evaluate the association between menstrual cup use and IUD...
Article
Do ObGyns think hormonal contraception should be offered over the counter?
Expert Commentary
Learning to live with COVID-19: Postpandemic life will be reflected in how effectively we leverage this crisis
Four strategies can help us navigate through the COVID-19 health emergency, and lessons learned can guide thinking on future...
News for Your Practice
ACOG offers guidance on optimizing patient care in the midst of COVID-19
Conference Coverage
How can neurologists diagnose and treat menstrual migraine?
STOWE, VT. – The disorder is associated with greater disability than nonmenstrual migraine and may be harder to...
Expert Commentary
Can a drug FDA approved for endometriosis become a mainstay for nonsurgical treatment of HMB in women with fibroids?
Elagolix is a GnRH antagonist that is approved in a 2-dose schedule for treatment of endometriosis. It is given...